🇺🇸 FDA
Pipeline program

NKTR-102

12-102-12

Phase 1 small_molecule completed

Quick answer

NKTR-102 for Advanced Cancer is a Phase 1 program (small_molecule) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).

Program details

Company
NEKTAR THERAPEUTICS
Indication
Advanced Cancer
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials